Edward M Gilbert Selected Research

Carvedilol (Coreg)

4/2015	Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.
8/2009	Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
1/2009	Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure.
1/2009	Carvedilol produces sustained long-term benefits: follow-up at 12 years.
8/2008	Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.
5/2007	Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
1/2007	Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.
12/2006	Predictors of clinical outcomes in patients given carvedilol for heart failure.
10/2006	COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
12/2005	Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward M Gilbert Research Topics

Disease

26	Heart Failure 01/2022 - 01/2002
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2020 - 05/2002
5	Ventricular Remodeling 11/2017 - 07/2004
2	Hemorrhage 11/2018 - 05/2013
2	Pulmonary Hypertension 12/2010 - 04/2007
2	Infections 04/2007 - 01/2006
2	Left Ventricular Dysfunction 07/2004 - 05/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018
1	Right Ventricular Dysfunction 11/2018
1	Chronic Renal Insufficiency 11/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Hypotension (Low Blood Pressure) 10/2017
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Hemolysis 05/2013
1	Body Weight (Weight, Body) 10/2010
1	Hyponatremia 10/2010
1	Cognitive Dysfunction 10/2010
1	Hypokalemia 10/2010
1	Insulin Resistance 01/2009
1	Cardiogenic Shock 08/2007
1	Diabetes Mellitus 01/2007
1	Atrial Fibrillation 10/2006
1	Pathologic Constriction (Stenosis) 03/2006
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2006
1	Disease Progression 05/2004
1	Hypertrophy 05/2002

Drug/Important Bio-Agent (IBA)

12	Carvedilol (Coreg)FDA LinkGeneric 04/2015 - 05/2002
4	Metoprolol (Toprol-XL)FDA LinkGeneric 04/2015 - 05/2002
3	Messenger RNA (mRNA)IBA 09/2020 - 05/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2009
2	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2015 - 05/2002
2	EnoximoneIBA 11/2010 - 11/2007
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Pharmaceutical PreparationsIBA 10/2017
1	nitroxylIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Adenosine Triphosphatases (ATPase)IBA 04/2015
1	Contractile ProteinsIBA 04/2015
1	Natriuretic PeptidesIBA 04/2015
1	Hemoglobins (Hemoglobin)IBA 05/2013
1	Dobutamine FDA LinkGeneric 11/2010
1	SodiumIBA 10/2010
1	lixivaptanIBA 10/2010
1	ElectrolytesIBA 10/2010
1	Vasopressins (Vasopressin)IBA 10/2010
1	Antidiuretic Hormone Receptor AntagonistsIBA 10/2010
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2009
1	Terbutaline (Brethaire)FDA LinkGeneric 01/2009
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 08/2008
1	CreatinineIBA 01/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2006
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2006
1	MetalsIBA 03/2006
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 07/2004
1	Atrial Natriuretic Factor (ANF)IBA 05/2002
1	RNA (Ribonucleic Acid)IBA 05/2002
1	beta Adrenergic ReceptorsIBA 05/2002
1	Protein Isoforms (Isoforms)IBA 05/2002
1	Ventricular MyosinsIBA 05/2002
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 05/2002

Therapy/Procedure

8	Heart-Assist Devices 01/2022 - 09/2006
8	Therapeutics 11/2010 - 01/2002
4	Transplantation 05/2013 - 09/2006
3	Heart Transplantation (Grafting, Heart) 12/2010 - 01/2006
2	Length of Stay 04/2007 - 01/2006
1	Patient Readmission 10/2010
1	Sternotomy 01/2007
1	Aftercare (After-Treatment) 10/2006
1	Stents 03/2006
1	Drug-Eluting Stents 03/2006